ScoreWhy is Changzhou Qianhong Biopharma Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -1.97% and Operating profit at 15.50% over the last 5 years
2
The company has declared Positive results for the last 3 consecutive quarters
- ROCE(HY) Highest at 16.45%
- RAW MATERIAL COST(Y) Fallen by -11.56% (YoY)
- NET PROFIT(9M) Higher at CNY 380.07 MM
3
With ROE of 15.34%, it has a attractive valuation with a 4.38 Price to Book Value
- Over the past year, while the stock has generated a return of 19.65%, its profits have risen by 67.7% ; the PEG ratio of the company is 0.4
- At the current price, the company has a high dividend yield of 1.3
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Changzhou Qianhong Biopharma Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Changzhou Qianhong Biopharma Co., Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Changzhou Qianhong Biopharma Co., Ltd.
25.79%
0.52
43.91%
China Shanghai Composite
13.33%
0.90
14.74%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-1.97%
EBIT Growth (5y)
15.50%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.40
Sales to Capital Employed (avg)
0.67
Tax Ratio
16.44%
Dividend Payout Ratio
42.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.99%
ROE (avg)
8.97%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
4.38
EV to EBIT
24.05
EV to EBITDA
20.83
EV to Capital Employed
6.46
EV to Sales
6.95
PEG Ratio
0.42
Dividend Yield
1.33%
ROCE (Latest)
26.86%
ROE (Latest)
15.34%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
ROCE(HY)
Highest at 16.45%
RAW MATERIAL COST(Y)
Fallen by -11.56% (YoY
NET PROFIT(9M)
Higher at CNY 380.07 MM
CASH AND EQV(HY)
Highest at CNY 2,068.53 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 5.08 times
-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Here's what is working for Changzhou Qianhong Biopharma Co., Ltd.
Cash and Eqv
Highest at CNY 2,068.53 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio
Highest at 5.08 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Profit
Higher at CNY 380.07 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Profit (CNY MM)
Raw Material Cost
Fallen by -11.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
